Clinical Trials Browser

Phase 1 × infigratinib × Genitourinary × Clear all

NCT04972253 2022-08-10

(BLASST)-3

Phase 1 Withdrawn

Acrocephalosyndactylia, Urinary Bladder Neoplasms

NCT01004224 2019-10-04

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Phase 1 Completed

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms